Diagnosing joint diseases using biomarkers from joint fluid and tissue
Official title: "Translating Articular Biomarkers Into Diagnoses"
Run by Assistance Publique - Hôpitaux de Paris · NCT06312943 · Data updated 2026-11-12
This observational study tests whether new and traditional biomarkers from synovial fluid, blood, or joint tissue can help diagnose inflammatory and non-inflammatory joint diseases earlier and more accurately.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Paris, IDF) |
| Status | Recruiting |
| Started | June 2, 2026 |
| Main results expected | June 2029 |
| Study ends | August 2029 |
| Registry record updated | June 24, 2026 |
| Trial ID | NCT06312943 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 and older with inflammatory or non-inflammatory bone and joint diseases requiring synovial fluid aspiration or joint replacement, who can communicate in French.
✕Probably not a fit
Patients who do not require joint fluid collection or tissue samples, or who cannot communicate in French, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will collect joint fluid or tissue samples from adults with bone and joint diseases to explore biomarkers from both conventional tests and newer methods like Raman spectroscopy. The study aims to see if these biomarkers can refine diagnoses and better classify patients who currently have unclear or unclassified rheumatic conditions. No intervention beyond sample collection is planned, and analysis will focus on diagnostic information from the specimens. Findings could improve early detection and inform treatment decisions in rheumatic diseases.
Why it matters
Potential benefit: If successful, the approach could lead to earlier and more accurate diagnoses for patients with unclear joint diseases.
How similar studies have gone: Previous work in this area has shown promise with biomarker-based approaches, but the combination with Raman and nanospectroscopy in routine diagnostic pathways is still evolving.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * Inflammatory and non-inflammatory bone and joint diseases requiring synovial fluid aspiration and/or joint replacement * Collection of non-opposition * Affiliated to or beneficiary of social security Exclusion Criteria: * Inability to speak and/or read French * Neoadjuvant therapy * Patients under tutor or curatorship * Protected adults, * Patients benefiting of State Medical Aid
Where it's running
-
Service de Médecine Physique et de Réadaptation, Hôpital Cochin
Paris, Idf, France Recruiting
Study contacts
- Principal investigator: Christelle Nguyen, MD, PhD — Service de Médecine Physique et de Réadaptation, Hôpital Cochin
- Study coordinator: Christelle Nguyen, MD, PhD
- Email: christelle.nguyen2@aphp.fr
- Phone: 00 33 1 58 41 29 45
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Improving Care for underserved older Black patients with cardiovascular and other chronic conditions
This study tests a culturally tailored approach to patient-centered care for older African American patients with cardiovascular disease and other conditions who receive care at a community hospital.
-
Oxidative stress in autoimmune joint diseases
Researchers will see if oxidative stress and antioxidant markers differ in adults with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.
-
Observational study on the effectiveness of biological treatments for inflammatory joint diseases
This study is testing how well biological treatments work for people with inflammatory joint diseases like rheumatoid arthritis and psoriatic arthritis, while also looking at their safety over time.
-
Tornier Perform Reversed MonoPost Shoulder Implant: Patient Follow-Up in Real World Care
This study tests how well the Tornier Perform Reversed MonoPost shoulder implant works in adults with shoulder problems over two years by following patients after surgery at multiple centers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.